These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27249100)

  • 21. Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer.
    Mayer RJ; Hochster HS; Cohen SJ; Winkler R; Makris L; Grothey A
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):961-969. PubMed ID: 30350179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts.
    Suzuki N; Nakagawa F; Matsuoka K; Takechi T
    Oncol Rep; 2016 Dec; 36(6):3123-3130. PubMed ID: 27805254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo.
    Emura T; Suzuki N; Fujioka A; Ohshimo H; Fukushima M
    Int J Oncol; 2005 Aug; 27(2):449-55. PubMed ID: 16010427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer.
    Van Cutsem E; Geboes K
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1089-108. PubMed ID: 18070705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine alone.
    Cleary JM; Rosen LS; Yoshida K; Rasco D; Shapiro GI; Sun W
    Invest New Drugs; 2017 Apr; 35(2):189-197. PubMed ID: 28111727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TAS-102 (Lonsurf) for the Treatment of Metastatic Colorectal Cancer. A Concise Review.
    Zaniboni A; Bertocchi P; Barni S; Petrelli F
    Clin Colorectal Cancer; 2016 Dec; 15(4):292-297. PubMed ID: 27431756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidine phosphorylase (TP) activation: convenience through innovation.
    Van Cutsem E; Cunningham D; Hoff PM; Maroun J
    Oncologist; 2001; 6 Suppl 4():1-2. PubMed ID: 11585967
    [No Abstract]   [Full Text] [Related]  

  • 29. TAS-102 for Treatment of Advanced Colorectal Cancers That Are No Longer Responding to Other Therapies.
    van der Velden DL; Opdam FL; Voest EE
    Clin Cancer Res; 2016 Jun; 22(12):2835-9. PubMed ID: 27126991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer.
    Kasper S; Kisro J; Fuchs M; Müller C; Schulz-Abelius A; Karthaus M; Rafiyan MR; Stein A
    BMC Cancer; 2018 Nov; 18(1):1124. PubMed ID: 30445951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging phase 3 data in relapsed/refractory metastatic colorectal cancer.
    Goldberg R
    Clin Adv Hematol Oncol; 2016 Jan; 14(1):30-3. PubMed ID: 27057664
    [No Abstract]   [Full Text] [Related]  

  • 32. Long Term Real-World Outcomes of Trifluridine/Tipiracil in Metastatic Colorectal Cancer-A Single UK Centre Experience.
    Tong D; Wang L; Mendis J; Essapen S
    Curr Oncol; 2021 Jun; 28(3):2260-2269. PubMed ID: 34207352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.
    Meropol NJ; Gold PJ; Diasio RB; Andria M; Dhami M; Godfrey T; Kovatich AJ; Lund KA; Mitchell E; Schwarting R
    J Clin Oncol; 2006 Sep; 24(25):4069-77. PubMed ID: 16943524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Doxifluridine for treatment of colorectal cancer].
    Nishimura G; Miwa K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():345-8. PubMed ID: 14574909
    [No Abstract]   [Full Text] [Related]  

  • 35. On 5-fluorouracil therapy of colorectal cancer.
    Jensen SA
    Dan Med J; 2013 Jul; 60(7):B4603. PubMed ID: 23809976
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical development of eniluracil: current status.
    Hohneker JA
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):52-6. PubMed ID: 9830627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe neutropenia: a prognosticator in patients with advanced/recurrent colorectal cancer
    Kimura M; Usami E; Iwai M; Teramachi H; Yoshimura T
    Pharmazie; 2017 Jan; 72(1):49-52. PubMed ID: 29441897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
    Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer.
    Kimura M; Usami E; Teramachi H; Yoshimura T
    Anticancer Res; 2019 Feb; 39(2):1029-1034. PubMed ID: 30711991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Nukatsuka M; Nakagawa F; Takechi T
    Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.